Literature DB >> 23971775

Interventional therapy for the treatment of severe hemobilia after percutaneous transhepatic cholangial drainage: a case series.

Huicun Cao1, Jian Liu, Tianxiao Li, Guangshao Cao, Gangqin Xu, Shuiting Zhai, Jiangyu Xue, Ziliang Wang, Shuaitao Shi, Weixing Bai.   

Abstract

From May 2003 to May 2010, a total of 9 patients with severe hemobilia after percutaneous transhepatic cholangial drainage (PTCD) were diagnosed using superselective angiography and cholangiography, and then were treated with interventional procedures. Two patients with hepatic arterio-biliary fistula underwent proximal and distal arterial embolization of the responsible vessel. Six patients with pseudoaneurysm had pseudoaneurysm occlusion with proximal and distal embolization. Another patient with biliary-portal vein fistula received a biliary fully covered stent placement. The effects in these patients were evaluated using superselective angiography immediately after the intervention and at 3- and 6-month follow-up. In all patients, hemobilia was stopped right after the treatment and no sign of recurrence was noted at 3- and 6-month follow-up after the interventional therapy. Our findings demonstrate that interventional therapy is a simple, minimally invasive, and safe approach for treating severe hemobilia in patients receiving PTCD.

Entities:  

Mesh:

Year:  2013        PMID: 23971775      PMCID: PMC3756844          DOI: 10.9738/INTSURG-D-13-CC194

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  12 in total

Review 1.  Complications of percutaneous transhepatic biliary interventions.

Authors:  A B Winick; P N Waybill; A C Venbrux
Journal:  Tech Vasc Interv Radiol       Date:  2001-09

2.  Post cholecystectomy hemobilia: transcatheter embolization of pseudoaneurysms with homemade steel coils.

Authors:  Rajeev Jain; Yogesh Batra; Subrat Kumar Acharya
Journal:  Indian J Gastroenterol       Date:  2002 Jul-Aug

3.  Incidence of important hemobilia following transhepatic biliary drainage: left-sided versus right-sided approaches.

Authors:  G M Rivera-Sanfeliz; O S A Assar; J M LaBerge; M W Wilson; R L Gordon; E J Ring; R K Kerlan
Journal:  Cardiovasc Intervent Radiol       Date:  2004 Mar-Apr       Impact factor: 2.740

4.  Treatment of tumor associated hemobilia with a partially covered metallic stent.

Authors:  R Rerknimitr; P Kongkam; P Kullavanijaya
Journal:  Endoscopy       Date:  2007-07-05       Impact factor: 10.093

5.  Percutaneous transhepatic biliary drainage--twelve years' experience.

Authors:  G M Gazzaniga; A Faggioni; G Bondanza; C Bagarolo; M Filauro
Journal:  Hepatogastroenterology       Date:  1991-04

Review 6.  Transcatheter arterial embolization for iatrogenic hemobilia is a safe and effective procedure: case series and review of the literature.

Authors:  Thomas Marynissen; Geert Maleux; Sam Heye; Johan Vaninbroukx; Wim Laleman; David Cassiman; Chris Verslype; Schalk Van der Merwe; Werner Van Steenbergen; Frederik Nevens
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-08       Impact factor: 2.566

7.  Hepatic artery angiography and embolization for hemobilia after hepatobiliary surgery.

Authors:  Z Peng; S Yan; X Zhou; Z Xu
Journal:  Chin Med J (Engl)       Date:  2001-08       Impact factor: 2.628

8.  Transcatheter microcoil embolotherapy for ruptured pseudoaneurysm following pancreatic and biliary surgery.

Authors:  Toshiya Shibata; Tadashi Sagoh; Fumie Ametani; Yoji Maetani; Kyo Itoh; Junji Konishi
Journal:  Cardiovasc Intervent Radiol       Date:  2002-05-20       Impact factor: 2.740

Review 9.  Haemostasis impairment in patients with obstructive jaundice.

Authors:  Vassilios Papadopoulos; Dimitrios Filippou; Evangelos Manolis; Konstantinos Mimidis
Journal:  J Gastrointestin Liver Dis       Date:  2007-06       Impact factor: 2.008

10.  Pseudoaneurysm of the cystic artery with hemobilia treated by arterial embolization and elective cholecystectomy.

Authors:  Atsuyuki Maeda; Takao Kunou; Satomi Saeki; Keiya Aono; Toru Murata; Noriji Niinomi; Shumpei Yokoi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002
View more
  6 in total

1.  Iatrogenic hemobilia: imaging features and management with transcatheter arterial embolization in 30 patients.

Authors:  Wen Feng; Dong Yue; Lu ZaiMing; Liu ZhaoYu; Zhao XiangXuan; Li Wei; Guo QiYong
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

2.  Delayed Severe Hemobilia Due to Bilio-venous Fistula After Percutaneous Transhepatic Biliary Drainage: Treatment With Covered Stent Placement.

Authors:  Kumble S Madhusudhan; Nihar R Dash; Adil Afsan; Shivanand Gamanagatti; Deep N Srivastava; Arun K Gupta
Journal:  J Clin Exp Hepatol       Date:  2016-02-26

Review 3.  Diagnosis and management of hemorrhagic complications of percutaneous transhepatic biliary drainage: a primer for residents.

Authors:  Vishnu Prasad Pulappadi; Deep Narayan Srivastava; Kumble Seetharama Madhusudhan
Journal:  Br J Radiol       Date:  2021-02-02       Impact factor: 3.039

4.  Biliopleural fistula following percutaneous transhepatic cholangiodrainage and irradiation biliary stent insertion successfully treated with coil embolization: a case description.

Authors:  Fulei Gao; Tianfan Pan; Yong Wang; Guangyu Zhu; Yadong Feng; Cuifang Zhu; Jinhe Guo
Journal:  Quant Imaging Med Surg       Date:  2022-02

5.  Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.

Authors:  Ningjia Shen; Dadong Zhang; Lei Yin; Yinghe Qiu; Jian Liu; Wenlong Yu; Xiaohui Fu; Bin Zhu; Xiaoya Xu; Anqi Duan; Zishuo Chen; Xiang Wang; Xinkai Cao; Teng Zhao; Zisong Zhou; Lianghe Yu; Hao Qin; Zheng Fang; Jing-Yu Li; Yuanjin Liu; Lei Xiong; Bo Yuan; Fugen Li; Yongjie Zhang
Journal:  Oncol Rep       Date:  2019-05-31       Impact factor: 3.906

6.  Improving rehabilitation and quality of life after percutaneous transhepatic cholangiography drainage with a rapid rehabilitation model.

Authors:  Lu-Lu Xia; Ting Su; Yan Li; Jun-Fang Mao; Qi-Hong Zhang; Yang-Yan Liu
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.